Patent attorney Bernie Brown is a former assistant professor in the Department of Chemistry and Biochemistry at Wake Forest University. Bernie uses this extensive background in research to help his clients protect technologies relating to biotechnology, biochemistry, immunology, molecular biology, chemistry, and pharmaceuticals.
His experience includes U.S. and foreign prosecution; reexamination requests; patentability, freedom-to-operate, and prior art searches; invalidity and non-infringement opinions; portfolio management in view of the FDA regulatory process; pre-litigation Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) strategy, Inter Partes Reviews, and USPTO PTAB and Federal Circuit Appeals.
Bernie has experience with pharmaceuticals, biopharmaceuticals, biotechnological processes, human blood products, medical diagnostics, agricultural biotechnology, plant patents and medical devices. Bernie counsels clients on strategically protecting and commercializing their intellectual property, patent portfolio and life cycle management, licensing, and business development. He works with clients across all stages of development to secure their inventions, evaluate potential competitors, advise them on navigating the patent space, and maximize their IP value.
Bernie serves as externally seconded IP counsel for a specialty pharmaceutical company. This experience has provided him with a practical understanding of the challenges of managing business goals and expectations with commercially valuable IP protection while controlling costs.
Before his joining Wake Forest University, Bernie conducted biochemistry, structural biology, and biophysical research as a postdoctoral fellow at the Massachusetts Institute of Technology. He has authored more than 25 scientific articles and book chapters, has presented frequently on life sciences and intellectual property topics, and holds a patent related to generating monoclonal antibodies that recognize multi-stranded DNA complexes.